About
Dr. Holzbaur joined GeneChem in 1999. In 2002, she was promoted to vice president in the context of the closing of the Technologies Fund. In 2006, with the raising of the AgeChem Fund, she became General Partner. Dr. Holzbaur currently co-manages the latest Fund, AmorChem. She has held several positions as board member of GeneChem portfolio companies in Canada, the US and Europe. Most notably, she was a member of the board of BioVex inc. and Argos Therapeutics inc. She obtained her PhD in chemistry, studying the stereospecificity of the biosynthesis of erythromycin at Cambridge University and before joining GeneChem, was a consultant in the Department of Food Science of McGill University. Her work has been published in Chemistry and Biology, the Journal of the American Chemical Society, Biochemistry and a review of infra-red spectroscopy.
Position in the VCSift Database
- • 6 investors at GeneChem are tracked.
- • 626 investors hold the General Partner role in VCSift. Inès Holzbaur is one of them.
- • 686 investors are based in Montreal, Quebec, Canada.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Montreal, Canada
Contact Information
Find more investors like Inès
Search Investors